During the past decade, Sanofi-Aventis conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanofi-Aventis" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "Cancer International Research Group (CIRG)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Sanofi-Aventis" are "Diabetes Mellitus, Type 2" (2 trials), "Acute Coronary Syndromes" (1 trials), "Breast Cancer" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Sanofi-Aventis" in a lesser frequency.

Most popular intervention types in "Sanofi-Aventis" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Clopidogrel (SR25990)" (1 trials), "Docetaxel,doxorubicin, cyclophosphamide" (1 trials), "Doxorubicine + docetaxel sequential" (1 trials), "Insulin Detemir" (1 trials) and "Insulin Glargine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sanofi-Aventis" are 3 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Sanofi-Aventis". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Sanofi-Aventis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sanofi-Aventis, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".